The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...

The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...

Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged The Food and Drug Administration (FDA) has granted emergency use ...

The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...

People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...

One solution proposed to the current shortage of monkeypox vaccine has been to consider 'dose sparing' to make supplies stretch further. This involves using one vial of the Imvanex/Jynneos vaccine, ...

Hi, it’s Dong in London. Supplies of the world’s only approved vaccine for monkeypox are running low, and countries from the US to the UK recommend stretching available doses by using intradermal ...

On Tuesday, Riverside County received 690 vials of the monkeypox vaccine from the California Department of Public Health. But as monkeypox cases continue to grow in the Coachella Valley, there’s not ...

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...

First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...

To the Editor: In 1950 Abrams 1 reported his experience in ablating the referred pain of uterine contractions in the first stage of labor by means of intradermal injections of an anesthetic agent.